GlassScriptPhysician profile
Danielle M Shaholli
NPI 1205119039
$2,517.66
in general payments reported to CMS, 2019-2025
34 companies · $355 in 2025
The $355 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $464 · 2022: $625 · 2023: $688 · 2024: $385 · 2025: $355.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,429.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,428.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $362.70 | 2022-2024 | Venclose Maven Catheter |
| Axonics, INC. | $243.76 | 2021-2022 | |
| Veryan Medical Incorporated | $239.32 | 2022-2023 | Biomimics 3d Vascular Stent System |
| Medtronic, INC. | $189.83 | 2022-2024 | Abre, Endurant Iis, Closurefast |
| Cordis US Corp. | $158.09 | 2023 | S.M.A.R.T., Mynxgrip |
| Smith+Nephew, INC. | $123.19 | 2023-2025 | Oasis, Renasys Go V2 Home, Renasys Touch |
| Terumo Medical Corporation | $120.38 | 2022-2025 | Glidewire, Glidesheath Slender, Navicross |
| Cardiovascular Systems INC. | $119.79 | 2022-2023 | |
| Allergan, INC. | $97.85 | 2021-2022 | |
| Janssen Biotech, INC. | $86.88 | 2021 | |
| Angiodynamics, INC. | $74.70 | 2022-2025 | Auryon Laser System 100-120 Vac |
| Tactile Systems Technology INC | $64.78 | 2024-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Kerecis Limited | $63.45 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Graftguide |
| Astellas Pharma US INC | $49.43 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $42.98 | 2023-2024 | Xarelto |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $42.29 | 2023 | Diamondback Peripheral |
| Getinge USA Sales, LLC | $37.68 | 2025 | Flixene |
| Abbvie INC. | $36.19 | 2022 | |
| Baxter Healthcare | $35.96 | 2024 | Preveleak |
| Boston Scientific Corporation | $33.74 | 2023-2024 | Eluvia |
| Cashflow Solutions, LLC | $32.21 | 2024-2025 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
| Stryker Corporation | $29.60 | 2025 | Artix Mt |
| Reflow Medical INC | $28.70 | 2025 | |
| Clarus Therapeutics INC. | $24.50 | 2021 | |
| Shockwave Medical, INC | $22.62 | 2022 | |
| 180 Medical, INC. | $22.40 | 2021 | |
| Antares Pharma, INC. | $19.66 | 2022 | |
| Solventum Corporation | $18.69 | 2024 | Activ.A.C., V.A.C.Ulta, Prevena |
| Bayer Healthcare Pharmaceuticals INC. | $17.33 | 2022 | |
| Acera Surgical, INC. | $17.29 | 2023 | Restrata Wound Matrix |
| Myovant Sciences INC. | $17.24 | 2022 | |
| Blue Earth Diagnostics | $16.15 | 2021 | |
| Dentsply Ih INC. | $15.92 | 2021 | |
| Myriad Genetic Laboratories, INC. | $12.36 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Shaholli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.